LASIK Expert Dr. James Salz was interviewed in an article published by WebMD entitled “LASIK Surgery: Safer Than Contacts? Analysis Shows Higher Long-Term Risk of Infections for Contact Lens Wearers.” In the article, Dr. Salz discusses the risks of infection from contact lenses and new laser eye procedures that reduce the risk of complications.

Los Angeles, CA -- (ReleaseWire) -- 10/25/2006 -- Dr. James Salz (www.drsalz.com) Dr. James Salz was interviewed in a WebMD article entitled "LASIK Surgery: Safer Than Contacts? Analysis Shows Higher Long-Term Risk of Infections for Contact Lens Wearers." The article was published on October 10, 2006. In the article, Dr. James Salz discusses the risks of infection from contact lenses and new laser eye procedures that reduce the risk of complications. Dr. James Salz indicated that sleeping in contact lenses, even those approved for such purposes, can significantly increase the risk of infection. Dr. Salz also points out that better lasers and better training have reduced complications, particularly with the introduction of the Wavefront LASIK. To read the article, please click on the below link:

http://www.webmd.com/content/Article/71/81321.htm?printing=true

For more information on custom cornea wavefront-based LASIK, please click on the below link:

http://drsalz.com/documents/Alcon.pdf

About Laser Eye Associates, Inc.

Laser Eye Associates of Los Angeles, Inc. ("Laser Eye Associates") is an association consisting of about 30 LASIK and laser eye surgeons in the Beverly Hills/Los Angeles area. Laser Eye Associates is one of the few laser vision centers in the world with 3 different FDA approved excimer laser systems (Alcon, Visx and Alegretto): a femtosecond laser (Intralase) for creating the LASIK flap without a blade; (2) a Holmium laser system for treating low degrees of hyperopia; and (3) the only FDA approved procedure for treating presbyopia (the condition which requires reading glasses after age 40 the Refractec Conductive Keratoplasty (CK) instrument. Dr. James J. Salz is currently President of Laser Eye Associates and a shareholder of the company.

About Laser Vision Medical Associates

Laser Vision Medical Associates, Inc. (Laser Vision Medical Associates) (www.drsalz.com) is the refractive surgery medical private practice of Dr. James J. Salz, M.D. and is services patients in the Beverly Hills, Los Angeles, and Orange County regions of Southern California. Dr. James Salz, M.D. is the President and primary physician who performs laser vision surgery for the company. Dr. Salz has been researching and publishing studies as well as performing refractive surgery, including LASIK, for over 20 years. Dr. Salz is Clinical Professor of Ophthalmology at the University of Southern California and Co-Director of Refractive Surgery Research at the Discovery Fund for Eye Research at Cedars-Sinai Medical Center in Los Angeles. He has been the principal investigator for several major studies, including 8 FDA excimer laser studies, STAAR Surgical Implantable Contact Lens for Hyperopia FDA clinical trial. Dr. James Salz has been a paid consultant to Visx, and Alcon. Dr. James Salz is an expert of special interest in all aspects of refractive surgery, including LASIK, PRK, and Phakic implants. Dr. James Salz is also an expert in cataract surgery and lens implantation as well as medical legal matters and device and method patents related to ophthalmology. Dr. James Salz has an extensive listing of publications he has written or edited (www.drsalz.com/publicat.html), and spoken at hundreds of meetings concerning LASIK and other laser eye surgery procedures in the United States and abroad. For more information about Dr. Salz and LASIK and other laser eye surgery procedures, please visit www.drsalz.com. For information about Dr. James Salz's unique qualifications for LASIK , please see www.drsalz.com/whychoose. Laser Vision Medical Associates performs its LASIK and laser eye surgery procedures at Laser Eye Associates.
SOURCE: Laser Vision Medical Associates
Laser Vision Medical Associates
Attn: Dr. James Salz
Cedars-Sinai Medical Center
at Mark Goodson Building
444 S. San Vicente Blvd, Suite 703
Los Angeles, CA. 90048

Contact: Donna Jones
Phone: (323) 653-3800
Email: donna@drsalz.com

Website: www.drsalz.com

About WebMD
WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications. WebMD is a subsidiary of Emdeon Corporation (Nasdaq: HLTH). The WebMD Health Network reaches approximately 30 million visitors a month through its leading owned and operated health sites that include WebMD Health, Medscape, MedicineNet, eMedicine, eMedicine Health, RxList and theheart.org.
WebMD(R), WebMD Health(R), Emdeon(TM), Emdeon Business Services(TM), Medscape(R), eMedicine(R) and Summex(R), and POREX(R) are trademarks of Emdeon Corporation or its subsidiaries.

CONTACT: Media - Jennifer Newman, jnewman@webmd.net, (212) 624-3912
Web site: http://www.webmd.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Los Angeles, CA -- (ReleaseWire) -- 06/07/2006 -- Dr. James J. Salz gave two lectures at the International Congress meeting of the Italian Society of Ophthalmology in Rome, Italy, which took place from May 17-20, 2006. This meeting was also a regional meeting of the International Society of Refractive Surgeons of the American Academy of Ophthalmology. Dr. Salz has been past chair of this Society and is currently on its executive committee. Dr. Salz gave one lecture on intraocular lens calculations after refractive surgery and a second on the pre and post-operative management of LASIK patients with large nighttime pupils.

"I enjoyed the opportunity to interact with over 2,000 colleagues from Europe at this important meeting," said Dr. James Salz.

Laser eye surgery involves reshaping the cornea, the outer lens of the eye, with an excimer laser beam, to correct nearsightedness, farsightedness and astigmatism. Laser vision correction was first approved by the FDA in 1996 and the procedure has undergone multiple refinements since the original approval including flap creation with a laser instead of a blade and customized wavefront based treatments which improve the chances of obtaining 20/20 vision or better and provide better quality vision with fewer side effects such a night glare and halos

LASIK is a popular form of laser eye surgery uses a combination of automated lamellar keratoplasty (ALK) using a microkeratome (FDA approved) to create a "flap" and the excimer laser (FDA approved) to reshape the cornea ("zap"). LASIK is the most commonly performed laser eye procedure worldwide.

About Laser Vision Medical Associates

Laser Vision Medical Associates, Inc. (www.drsalz.com) is a refractive surgery medical practice based in the Beverly Hills, CA area. Doctor James Salz, M.D. is the President and primary physician who performs laser vision surgery. Dr. Salz has been researching and publishing studies as well as performing refractive surgery, including LASIK, for almost 30 years. Dr. Salz is Clinical Professor of Ophthalmology at the University of Southern California and Co-Director of Refractive Surgery Research at the Discovery Fund for Eye Research at Cedars-Sinai Medical Center in Los Angeles. He has been the principal investigator for several major studies, including 8 FDA excimer laser studies, STAAR Surgical Implantable Contact Lens for Hyperopia FDA clinical trial. Dr. James Salz has been a paid consultant to Visx, and Alcon Summit Autonomous for LASIK. Dr. James Salz is an expert of special interest in all aspects of refractive surgery, including LASIK, PRK, and Phakic implants. Dr. James Salz is also an expert in cataract surgery and lens implantation as well as medical legal matters and device and method patents related to ophthalmology. Dr. James Salz has an extensive listing of publications he has written or edited (http://drsalz.com/publicat.html), and spoken at hundreds of meetings concerning Lasik and other laser eye surgery procedures in the United States and abroad. For more information about Dr. Salz, please visit www.drsalz.com. For information about Dr. James Salz's unique qualifications for Lasik, please see http://drsalz.com/whychoose.html.

SOURCE: Laser Vision Medical Associates
Laser Vision Medical Associates
Attn: Dr. James Salz
Cedars-Sinai Medical Center
at Mark Goodson Building
444 S. San Vicente Blvd, Suite 703
Los Angeles, CA. 90048

Contact: Donna Jones
Phone: (323) 653-3800
Email: donna@drsalz.com

Website: www.drsalz.com

International Society of Refractive Surgery
of the American Academy of Ophthalmology
PO Box 7424
San Francisco, CA 94109-7424

Phone: (415) 561-8581
Fax: (415) 561-8575
Email: member_services@aao.org

About Italian Ophthalmology Society

Societa' Oftalmologica Italiana
(Italian Ophthalmology Society)
Via Dei Mille 35
Roma 00185
Italy
Tel: (39-06) 4464514
http://www.soiweb.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Los Angeles, CA -- (ReleaseWire) -- 06/01/2006 -- Dr. James J. Salz (Dr. Salz) (www.drsalz.com) presented the results of the Alcon FDA Custom Cornea wavefront based LASIK clinical trial for farsighted astigmatism at the meeting of the American Society of Cataract and Refractive Surgeons in San Francisco on March 20, 2006. LASIK is the most commonly performed refractive surgery procedure and involves the creation of a thin flap in the cornea and the application of the excimer laser to reshape the corneal curvature. The study showed that wavefront-based LASIK in these patients resulted in better results in terms of uncorrected visual acuity and contrast sensitivity and reduced the induction of higher order aberrations compared to conventional LASIK with the Alcon system. Dr. James Salz received the Best Paper" of the session for his presentation on this form of LASIK.

"Just as in Alcon wavefront based CustomCornea LASIK for nearsightedness, the results in the farsighted eyes showed superior outcomes," stated Dr. James Salz. "A higher percentage of patients achieved uncorrected vision of 20/20 and 20/40. Visual quality was improved as evidenced by better contrast sensitivity and less increase in higher order aberrations when compared to conventional LASIK."

Laser eye surgery involves reshaping the cornea, the outer lens of the eye, with an excimer laser beam, to correct nearsightedness, farsightedness and astigmatism. Laser vision correction was first approved by the FDA in 1996 and the procedure has undergone multiple refinements since the original approval including flap creation with a laser instead of a blade and customized wavefront based treatments which improve the chances of obtaining 20/20 vision or better and provide better quality vision with fewer side effects such a night glare and halos.

LASIK is a popular form of laser eye surgery uses a combination of automated lamellar keratoplasty (ALK) using a microkeratome (FDA approved) to create a "flap" and the excimer laser (FDA approved) to reshape the cornea ("zap"). LASIK is the most commonly performed laser eye procedure worldwide.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm